Physicalactivity mayreduce therisk of breastcancersHER-2AbsoluteRiskWomen ages40+ shouldhave a clinicalbreast examat least yearlyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMorpheaMetastasisGermlineMutationGeneMutationFamilyHistoryAdjuvantTherapyLumpMastectomyBRCAGeneEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCheckpointInhibitorACChemotherapyAngiogenesisBevacizumabSelf-examinationPalbociclibStagingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PagetDiseaseGeneticCounselingCyclophosphamideMRIApoptosisMastodyniaPARPInhibitorsOligometastasesLumpectomyCytostaticKi-67RatePathologicResponseOvarianSuppressionAxillarySamplingDocetaxelmTORInhibitorsAnastrozoleAlopeciaGenomicTestingCapecitabine1 in 8womenGeneticPredispositionPalpationKappaEpsilonER+DimplingPaclitaxelIntraductalPapilloma5-FluorouracilAntiemeticDown-StagingNeoadjuvantTherapyAromataseInhibitorsChemopreventionMultimodalityTherapyRadiotherapyBrachytherapyCo-survivorLCISAdvocacyBilateralProphylacticMastectomyMethotrexateEstradiolBOCABreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CachexiaBreastTomosynthesisCytotoxicFISHAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinEstrogenBreastCancerHormoneReplacementTherapyECOGScoreAdenocarcinomaImmunotherapyCystTriple +/-BreastCancerTamoxifenTumorGradeMegestrolAcetateDoxorubicinLymphNodeStatusDoseDenseTherapyEGFRIn-situCarcinomaRelapseHormoneReceptorStatusFibroadenomaMultifocalTumorsRADCAMAntibodyTherapyPI3KinaseInhibitorsCMFChemotherapySERMTyrosine-KinaseInhibitorCDK4/6InhibitorsAyurvedaRaloxifenePhyllodesTumorChemotherapyBiopsyGailModelDefinitiveSurgeryER-PrecisionMedicineFlowCytometryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibGuaranteedRenewableInsuranceProgestinCalcificationsLymphoscintigraphyBI-RADSPhysicalactivity mayreduce therisk of breastcancersHER-2AbsoluteRiskWomen ages40+ shouldhave a clinicalbreast examat least yearlyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMorpheaMetastasisGermlineMutationGeneMutationFamilyHistoryAdjuvantTherapyLumpMastectomyBRCAGeneEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCheckpointInhibitorACChemotherapyAngiogenesisBevacizumabSelf-examinationPalbociclibStagingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PagetDiseaseGeneticCounselingCyclophosphamideMRIApoptosisMastodyniaPARPInhibitorsOligometastasesLumpectomyCytostaticKi-67RatePathologicResponseOvarianSuppressionAxillarySamplingDocetaxelmTORInhibitorsAnastrozoleAlopeciaGenomicTestingCapecitabine1 in 8womenGeneticPredispositionPalpationKappaEpsilonER+DimplingPaclitaxelIntraductalPapilloma5-FluorouracilAntiemeticDown-StagingNeoadjuvantTherapyAromataseInhibitorsChemopreventionMultimodalityTherapyRadiotherapyBrachytherapyCo-survivorLCISAdvocacyBilateralProphylacticMastectomyMethotrexateEstradiolBOCABreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CachexiaBreastTomosynthesisCytotoxicFISHAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinEstrogenBreastCancerHormoneReplacementTherapyECOGScoreAdenocarcinomaImmunotherapyCystTriple +/-BreastCancerTamoxifenTumorGradeMegestrolAcetateDoxorubicinLymphNodeStatusDoseDenseTherapyEGFRIn-situCarcinomaRelapseHormoneReceptorStatusFibroadenomaMultifocalTumorsRADCAMAntibodyTherapyPI3KinaseInhibitorsCMFChemotherapySERMTyrosine-KinaseInhibitorCDK4/6InhibitorsAyurvedaRaloxifenePhyllodesTumorChemotherapyBiopsyGailModelDefinitiveSurgeryER-PrecisionMedicineFlowCytometryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibGuaranteedRenewableInsuranceProgestinCalcificationsLymphoscintigraphyBI-RADS

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Physical activity may reduce the risk of breast cancers
  2. HER-2
  3. Absolute Risk
  4. Women ages 40+ should have a clinical breast exam at least yearly
  5. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  6. Morphea
  7. Metastasis
  8. Germline Mutation
  9. Gene Mutation
  10. Family History
  11. Adjuvant Therapy
  12. Lump
  13. Mastectomy
  14. BRCA Gene
  15. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  16. Checkpoint Inhibitor
  17. AC Chemotherapy
  18. Angiogenesis
  19. Bevacizumab
  20. Self-examination
  21. Palbociclib
  22. Staging
  23. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  24. Paget Disease
  25. Genetic Counseling
  26. Cyclophosphamide
  27. MRI
  28. Apoptosis
  29. Mastodynia
  30. PARP Inhibitors
  31. Oligometastases
  32. Lumpectomy
  33. Cytostatic
  34. Ki-67 Rate
  35. Pathologic Response
  36. Ovarian Suppression
  37. Axillary Sampling
  38. Docetaxel
  39. mTOR Inhibitors
  40. Anastrozole
  41. Alopecia
  42. Genomic Testing
  43. Capecitabine
  44. 1 in 8 women
  45. Genetic Predisposition
  46. Palpation
  47. Kappa Epsilon
  48. ER+
  49. Dimpling
  50. Paclitaxel
  51. Intraductal Papilloma
  52. 5-Fluorouracil
  53. Antiemetic
  54. Down-Staging
  55. Neoadjuvant Therapy
  56. Aromatase Inhibitors
  57. Chemoprevention
  58. Multimodality Therapy
  59. Radiotherapy
  60. Brachytherapy
  61. Co-survivor
  62. LCIS
  63. Advocacy
  64. Bilateral Prophylactic Mastectomy
  65. Methotrexate
  66. Estradiol
  67. BOCA
  68. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  69. Cachexia
  70. Breast Tomosynthesis
  71. Cytotoxic
  72. FISH
  73. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  74. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  75. Herceptin
  76. Estrogen
  77. Breast Cancer
  78. Hormone Replacement Therapy
  79. ECOG Score
  80. Adenocarcinoma
  81. Immunotherapy
  82. Cyst
  83. Triple +/- Breast Cancer
  84. Tamoxifen
  85. Tumor Grade
  86. Megestrol Acetate
  87. Doxorubicin
  88. Lymph Node Status
  89. Dose Dense Therapy
  90. EGFR
  91. In-situ Carcinoma
  92. Relapse
  93. Hormone Receptor Status
  94. Fibroadenoma
  95. Multifocal Tumors
  96. RAD
  97. CAM
  98. Antibody Therapy
  99. PI3 Kinase Inhibitors
  100. CMF Chemotherapy
  101. SERM
  102. Tyrosine-Kinase Inhibitor
  103. CDK4/6 Inhibitors
  104. Ayurveda
  105. Raloxifene
  106. Phyllodes Tumor
  107. Chemotherapy
  108. Biopsy
  109. Gail Model
  110. Definitive Surgery
  111. ER-
  112. Precision Medicine
  113. Flow Cytometry
  114. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  115. Lapatinib
  116. Guaranteed Renewable Insurance
  117. Progestin
  118. Calcifications
  119. Lymphoscintigraphy
  120. BI-RADS